-2%
Osimertinib 80 belongs to a class of protein kinase inhibitors primarily used to manage or treat lung cancer.
Osicent 80 is a type of protein kinase inhibitor used to treat lung cancer. Lung cancer is a condition where cancerous cells grow uncontrollably in the lung tissues.
The active ingredient in Osicent 80, Osimertinib, works by blocking specific proteins in cancer cells that promote their growth, thereby slowing or stopping the progression of advanced cancer.
It is essential to take Osicent 80 as prescribed by your doctor for the recommended duration to achieve the best results. Common side effects include diarrhea, rash, dry skin, nail issues, stomatitis (oral inflammation), fatigue, reduced appetite, and low blood cell counts. If any of these side effects persist or worsen, consult your doctor.
Before starting Osicent 80, inform your doctor about any known allergies or hypersensitivity to medications or foods. This medication can harm a developing fetus, so it is crucial to avoid pregnancy during treatment and for several months afterward. Effective contraception is strongly recommended while undergoing therapy with Osicent 80. If you or your partner becomes pregnant during treatment, contact your doctor immediately. Breastfeeding is generally not recommended while on this medication. Additionally, it is advised to avoid alcohol during treatment. The safety and effectiveness of Osicent 80 in children have not been established.